太极集团：拟对全资子公司增资4670万元

Core Viewpoint - The company, Chongqing Taiji Industry (Group) Co., Ltd., announced a capital increase of 46.7 million yuan for its wholly-owned subsidiary, Yuncheng Taiji Smart Traditional Chinese Medicine Co., Ltd., to enhance its financial stability and market competitiveness [1] Group 1: Capital Increase Details - The registered capital of Yuncheng Smart Traditional Chinese Medicine will increase from 300,000 yuan to 47 million yuan following the capital injection [1] - The capital increase aims to supplement the subsidiary's working capital, optimize its asset-liability structure, and enhance its capital strength and risk resistance [1] Group 2: Strategic Importance - The traditional Chinese medicine resource sector is a key component of the company's strategic planning [1] - The investment is intended to ensure stable supply of traditional Chinese medicine materials, strengthen market expansion, and cultivate core product brands [1] Group 3: Risk Management and Financial Impact - The company emphasized that the capital increase aligns with its strategic layout and long-term interests, with overall risks being controllable [1] - This action will not change the scope of the company's consolidated financial statements and is not expected to negatively impact its financial condition or operating results [1] - The company will enhance management of the subsidiary's operations and implement effective risk management and control measures [1]